Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 29;109(9):2496-501.
doi: 10.1038/bjc.2013.597. Epub 2013 Oct 1.

Cancer risk in patients with Hashimoto's thyroiditis: a nationwide cohort study

Affiliations

Cancer risk in patients with Hashimoto's thyroiditis: a nationwide cohort study

Y-K Chen et al. Br J Cancer. .

Abstract

Background: This study examined the risk of cancer in patients with Hashimoto's thyroiditis (HT).

Methods: The Taiwanese National Health Insurance Research Database (NHIRD) was used to identify 1521 newly diagnosed HT patients from 1998-2010, and 6084 frequency-matched non-HT patients. The risk of developing cancer for HT patients was measured using the Cox proportional hazard model.

Results: The incidence of developing cancer in the HT cohort was 5.07 per 1000 person-years, which was 1.68-fold higher than that in the comparison cohort (P<0.001). Compared with patients aged 20-34 years, patients in older age groups had a higher risk of developing cancer (35-55 years: hazard ratio (HR)=5.96; >55 years: HR=9.66). After adjusting for sex, age, and comorbidities, the HT cohort had HRs of 4.76 and 11.8 for developing colorectal cancer and thyroid cancer, respectively, compared with non-HT cohort. Furthermore, the HT cohort to non-HT cohort incidence rate ratio (IRR) of thyroid cancer was higher in the first 3 years (48.4, 95% confidence interval (CI)=35.0-66.3), with an adjusted HR of 49.4 (95% CI=6.39-382.4).

Conclusion: Hashimoto's thyroiditis patients have a higher risk of thyroid cancer and colorectal cancer. The thyroid cancer prevention effort should start soon after HT is diagnosed, while being cautious of colorectal cancer increases with time.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Probability free of colorectal cancer (A), and thyroid cancer (B) for patients with (dashed line) or without (solid line) Hashimoto's thyroiditis.

References

    1. Ahn D, Heo SJ, Park JH, Kim JH, Sohn JH, Park JY, Park SK, Park J. Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer. Acta Oncol. 2011;50 (8:1228–1234. - PubMed
    1. Anil C, Goksel S, Gursoy A. Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid. 2010;20 (6:601–606. - PubMed
    1. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow. Lancet. 2001;357 (9255:539–545. - PubMed
    1. Cheng TM.2009Taiwan's National Health Insurance System: High value for the dollarIn Okma KGH, Crivelli L eds. Six Countries, Six Reform Models: The Health Reform Experience of Israel, The Netherlands, New Zealand, Singapore, Swit zerland and Taiwan World Scientific: New Jersey; 71–204.
    1. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420 (6917:860–867. - PMC - PubMed

Publication types

LinkOut - more resources